ICS and mental health dashboard - new indicators and demos

The ICS and mental health dashboard is a bolt-on product that ICBs can commission to look at combined primary and secondary care prescribing data, to show patterns of medicines usage and support medicines optimisation initiatives across the system. They track the use of key medicines, highlight variation, identify MO opportunities, and benchmark ICS progress at a regional and national level.

New indicators recently added to the dashboard include:

  • Osteoporosis drugs
  • Thrombolytics used in the treatment of stroke
  • Thrombopoietin Receptor Agonists (TPO-Ras)
  • Prostate cancer drugs

The following indicators are also in development and hope to be added in due course:

  • Antifungal drugs
  • Growth hormone
  • Dementia drugs

Webinars are planned over the next few months to demonstrate the dashboards to subscribers, and update existing users on the new metrics.

If you would like to arrange a personal dashboard demonstration for you and your team, please contact Jo.